The harder we look, the more we find. Diagnoses of chronic lymphocytic leukemia (CLL) are becoming more common because we are looking harder. With sensitive techniques, a monoclonal population of B lymphocytes that is indistinguishable from CLL cells may be found in the blood of 3.5 percent of persons older than 40 years of age. Even without such sophisticated methods, simple immunophenotyping, which is available to all, easily singles out CLL from the many other causes of slight lymphocytosis. Such a finding will never have clinical effects in most people — they will die with it rather than from it . .
Objectives: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with various clinical find...
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized by the acc...
Autoimmune cytopenias (AIC) are frequent in chronic lymphocytic leukemia (CLL) patients, but risk fa...
The incidence and presenting features of chronic lymphocytic leukemia (CLL) have changed significant...
Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease. Some pati...
The diagnosis of chronic lymphocytic leukaemia (CLL) is based on clinical and laboratory features. M...
n the past 20 years important progress has been made in the understanding of chronic lymphoprolifera...
Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia among the elderly in the de...
Zeta-associated protein-70 (ZAP-70), mostly assessed by flowcytometry (FC), recently emerged as reli...
B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable cou...
Chronic lymphocytic leukemia (CLL) is a frequentCD5+ B-cell neoplasia that involves peripheralblood,...
Chronic lymphocytic leukemia (CLL) is one of the most commonly diagnosed leukemias managed by practi...
It has become clear that the heterogeneity of chronic lymphocytic leukaemia (CLL) is not a continuou...
Chronic lymphocytic leukemia (CLL) is clinically heterogeneous. While some patients have indolent di...
Disease overview Chronic lymphocytic leukemia (CLL) is the commonest leukemia in western countries. ...
Objectives: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with various clinical find...
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized by the acc...
Autoimmune cytopenias (AIC) are frequent in chronic lymphocytic leukemia (CLL) patients, but risk fa...
The incidence and presenting features of chronic lymphocytic leukemia (CLL) have changed significant...
Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease. Some pati...
The diagnosis of chronic lymphocytic leukaemia (CLL) is based on clinical and laboratory features. M...
n the past 20 years important progress has been made in the understanding of chronic lymphoprolifera...
Chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia among the elderly in the de...
Zeta-associated protein-70 (ZAP-70), mostly assessed by flowcytometry (FC), recently emerged as reli...
B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable cou...
Chronic lymphocytic leukemia (CLL) is a frequentCD5+ B-cell neoplasia that involves peripheralblood,...
Chronic lymphocytic leukemia (CLL) is one of the most commonly diagnosed leukemias managed by practi...
It has become clear that the heterogeneity of chronic lymphocytic leukaemia (CLL) is not a continuou...
Chronic lymphocytic leukemia (CLL) is clinically heterogeneous. While some patients have indolent di...
Disease overview Chronic lymphocytic leukemia (CLL) is the commonest leukemia in western countries. ...
Objectives: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with various clinical find...
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized by the acc...
Autoimmune cytopenias (AIC) are frequent in chronic lymphocytic leukemia (CLL) patients, but risk fa...